Skip to main content

Table 1 Functional roles of FOXO3a pathway in different types of cancer

From: Critical role of FOXO3a in carcinogenesis

Cancer types

Key message(s)

Ref.

Breast cancer

Dephosphorylation of FOXO3a induced by Aplysin suppresses tumor growth by inhibiting cell proliferation and promoting apoptosis in cancer cells.

[89]

Prostate cancer

Deregulation of FOXO3a promotes prostate cancer progression in TRAMP mice.

[90]

Acute myeloid leukemia

Dephosphorylation of FOXO3a induced by hypomethylating agents promote apoptosis by upregulation of BIM and PUMA expression.

[91]

Colon cancer

Activation of FOXO3a by aldose reductase induces human colon cancer cell apoptosis by upregulating both DR5 and DR4.

[92]

Lung cancer

Deregulation of FOXO3a promotes DNMT3B overexpression leading to tumor growth in lung cancer.

[93]

Glioma

A high expression of FOXO3a is associated with glioblastoma progression and FOXO3a level independently indicates poor prognosis in Glioma patients.

[94]

Thyroid cancer

Nuclear FOXO3a promotes cell cycle progression by transcriptional upregulation of cyclin A1 and accelerates proliferation of human ATC cells.

[95]

Lung adenocarcinoma

FOXO3a gene inactivation occurs frequently in carcinogen-induced lung adenocarcinoma.

[96]

Oral squamous cell carcinoma

Constitutively active form of FOXO3a induces significant G1-phase arrest and apoptosis in OSCC cells

[97]

Neck cancer

Tumor patients with low FOXO3a expression have a poor prognosis compared with patients with high FOXO3a.

[98]

Urothelial cancer

FOXO3a suppresses invasiveness of urothelial cancer through regulation of Twist1, YB-1 and E-cadherin.

[99]

Osteosarcoma

Activation of FOXO3a by ionizing radiation induces cell apoptosis in osteosarcoma.

[100]

Bladder cancer

Upregulation of FOXO3a by Nkx2.8 suppresses bladder cancer proliferation.

 

Gastric cancer

FOXO3a cooperates with RUNX3 to induce apoptosis by activating Bim in gastric cancer cells.

[60, 101]

Neuroblastoma

Inactivation of FOXO3a by AKT is essential for neuroblastoma cell survival.

[102]

Ovarian cancer

Inhibition of FOXO3a phosphorylation by BrMC upregulates Bim expression and leads to apoptosis in ovarian cancer cells.

[103]